Search Within

Rona Denit Yaeger

Formats
  1. Meeting Abstract (166)
  2. Journal Article (143)
  3. Review (7)
  4. Editorial (6)
  5. Research Letter (4)
  6. Book Section (1)
  7. Correspondence (1)
  8. Guidelines (1)
Groups
  1. Department of Medicine (329)
  2. Gastrointestinal Oncology Service (329)
  3. Solid Tumor Oncology Division (329)
  4. Center for Pancreatic Cancer Research (136)
  5. GSK Faculty (134)
  6. Department of Pathology and Laboratory Medicine (125)

More Groups

People
  1. Andrea Cercek Hanjis (95)
  2. Leonard Saltz (81)
  3. Jinru Shia (76)
  4. Martin Weiser (64)
  5. Zsofia Stadler (62)
  6. Julio Garcia Aguilar (61)

More People

Years
  1. 2025 (29)
  2. 2024 (41)
  3. 2023 (37)
  4. 2022 (39)
  5. 2021 (36)
  6. 2020 (28)

More Years

Publications
  1. Journal of Clinical Oncology (101)
  2. Annals of Oncology (37)
  3. Clinical Cancer Research (17)
  4. Cancer Research (15)
  5. Cancer Discovery (14)
  6. Nature Medicine (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (111)
  2. American Association for Cancer Research (51)
  3. Oxford University Press (48)
  4. Nature Publishing Group (26)
  5. Elsevier Inc. (19)
  6. Springer (10)

More Publishers

Results (329)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic profiling identifies differences in the distribution of APC mutations in non-Hispanic black and non-Hispanic white patients with colorectal cancer
    Meeting Abstract

    Walch, H.; Luthra, A.; Chatila, W.; Arora, K.; Chin, S.; Waters, M.; Smith, J. J.; Schultz, N.; Berger, M. F.; Ganesh, K.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitors for colorectal cancer in patients with inflammatory bowel disease
    Meeting Abstract

    Faleck, D. M.; Sharma, K.; Yaeger, R.; Kelsen, D.
    American Journal of Gastroenterology (2022)

    Fulltext@MSK | Save
  • Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer
    Journal Article

    Chatila, W. K.; Kim, J. K.; Walch, H.; Marco, M. R.; Chen, C. T.; Wu, F.; Omer, D. M.; Khalil, D. N.; Ganesh, K.; Qu, X.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Sotorasib in combination with panitumumab in refractory KRAS G12C-mutated colorectal cancer: Safety and efficacy for phase Ib full expansion cohort
    Meeting Abstract

    Kuboki, Y.; Yaeger, R.; Fakih, M.; Strickler, J. H.; Masuishi, T.; Kim, E. J. H.; Bestvina, C. M.; Langer, C. J.; Krauss, J. C.; Puri, S.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • BREAKWATER safety lead-in (SLI): Encorafenib (E) + cetuximab (C) + chemotherapy (chemo) for BRAFV600E metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Tabernero, J.; Yoshino, T.; Kim, T. W.; Yaeger, R.; Desai, J.; Wasan, H. S.; Van Cutsem, E.; Ciardiello, F.; Maughan, T.; Eng, C.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • KRYSTAL-1: Updated efficacy and safety of adagrasib (MRTX849) with or without cetuximab in patients with advanced colorectal cancer (CRC) harboring a KRASG12C mutation
    Meeting Abstract

    Klempner, S. J.; Weiss, J.; Pelster, M.; Spira, A.; Barve, M.; Ou, S. H. I.; Leal, A.; Bekaii-Saab, T.; Christensen, J. G.; Kheoh, T.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Characterizing the clinico-genomic landscape and outcomes of KRAS G12C mutated pancreas cancer
    Meeting Abstract

    Keane, F.; Park, W.; Varghese, A.; Balogun, F.; Yu, K.; El Dika, I.; Khalil, D.; Kelsen, D. P.; Reidy-Lagunes, D.; Ku, G. Y.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Efficacy of BRAF inhibitor FORE8394 in BRAF V600+ patients
    Meeting Abstract

    Sherman, E. J.; Tsai, F.; Janku, F.; Allen, C.; Yaeger, R.; Ammakkanavar, N.; Butowski, N.; Michelson, G.; Paz, M.; Tussay-Lindenberg, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Sotorasib in combination with panitumumab in refractory KRAS G12C-mutated colorectal cancer: Safety and efficacy for phase Ib full expansion cohort
    Meeting Abstract

    Kuboki, Y.; Yaeger, R.; Fakih, M. G.; Strickler, J. H.; Masuishi, T.; Kim, E. J.; Bestvina, C. M.; Langer, C. J.; Krauss, J. C.; Puri, S.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Genomic mechanisms of acquired resistance of patients (pts) with BRAF V600E-mutant (mt) metastatic colorectal cancer (mCRC) treated in the BEACON study
    Meeting Abstract

    Kopetz, S.; Murphy, D. A.; Pu, J.; Yaeger, R.; Ciardiello, F.; Desai, J.; Van Cutsem, E.; Wasan, H. S.; Yoshino, T.; Alkuzweny, B.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save